Myo-Inositol and D-Chiro-Inositol: The Two Forms That Matter
Inositol is a sugar-like compound that functions as a second messenger in cellular signalling, particularly for insulin and FSH (follicle-stimulating hormone). It exists in nine different stereoisomers, but only two have significant clinical applications: myo-inositol (MI) and D-chiro-inositol (DCI). These two forms are interconverted in the body and have different tissue distributions. Myo-inositol is the form most relevant to ovarian function and FSH signalling, while D-chiro-inositol is more involved in insulin signalling in skeletal muscle and adipose tissue. The two forms are sometimes combined in supplements for PCOS, though some practitioners prefer myo-inositol alone for ovarian indications.
Clinical Evidence for Inositol in PCOS
The largest and most consistent body of evidence for inositol in PCOS relates to its insulin-sensitising effects: supplementation with myo-inositol (typically 2-4g per day) has been shown in multiple RCTs to reduce fasting insulin, improve insulin sensitivity, reduce androgen levels (testosterone and androstenedione), and regulate menstrual cycles in women with PCOS. The combination of myo-inositol and D-chiro-inositol in the physiological ratio found in the body (40:1 MI:DCI) has shown particular promise for improving ovarian function and pregnancy rates in women with PCOS undergoing fertility treatment.
The Sugar Alcohol That Acts as a Second Messenger Inside Cells
Inositol is technically a sugar alcohol that serves as the backbone for lipid signalling molecules – specifically phosphatidylinositol phosphates (PIPs), which regulate cellular responses to hormones, neurotransmitters, and growth factors. Its role as a second messenger is why it influences such diverse systems: it is involved in insulin signalling, dopamine regulation, calcium mobilisation, and cellular membrane integrity. The two forms most relevant in supplement use are myo-inositol (the most common form, found in many foods) and D-chiro-inositol (which appears to have distinct tissue-specific effects).
Myo-inositol has the strongest evidence for PCOS support, where it improves insulin sensitivity in ovarian tissue and can restore spontaneous ovulation in some women. It also shows promise for mood regulation, particularly in panic disorder and binge eating, where it appears to modulate serotonin receptor sensitivity. The research landscape is still developing, but inositol excellent safety profile makes it an attractive option for conditions where conventional treatments have unsatisfactory risk-benefit ratios.
Why the Myo vs D-Chiro Ratio Matters for Specific Conditions
Different tissues convert myo-inositol to D-chiro-inositol at different rates. The conversion pathway appears to be impaired in PCOS, meaning women with PCOS may have adequate myo-inositol but deficient D-chiro-inositol at the ovarian level. This is why supplementation typically uses myo-inositol (often with small amounts of D-chiro) rather than D-chiro alone. A 40:1 myo to D-chiro ratio is common in PCOS formulations, reflecting the natural ratio found in healthy ovarian tissue.
The Sugar Alcohol That Acts as a Second Messenger Inside Cells
Inositol is technically a sugar alcohol that serves as the backbone for lipid signalling molecules – specifically phosphatidylinositol phosphates (PIPs), which regulate cellular responses to hormones, neurotransmitters, and growth factors. Its role as a second messenger is why it influences such diverse systems: it is involved in insulin signalling, dopamine regulation, calcium mobilisation, and cellular membrane integrity. The two forms most relevant in supplement use are myo-inositol (the most common form, found in many foods) and D-chiro-inositol (which appears to have distinct tissue-specific effects).
Myo-inositol has the strongest evidence for PCOS support, where it improves insulin sensitivity in ovarian tissue and can restore spontaneous ovulation in some women. It also shows promise for mood regulation, particularly in panic disorder and binge eating, where it appears to modulate serotonin receptor sensitivity. The research landscape is still developing, but inositol excellent safety profile makes it an attractive option for conditions where conventional treatments have unsatisfactory risk-benefit ratios.
Why the Myo vs D-Chiro Ratio Matters for Specific Conditions
Different tissues convert myo-inositol to D-chiro-inositol at different rates. The conversion pathway appears to be impaired in PCOS, meaning women with PCOS may have adequate myo-inositol but deficient D-chiro-inositol at the ovarian level. This is why supplementation typically uses myo-inositol (often with small amounts of D-chiro) rather than D-chiro alone. A 40:1 myo to D-chiro ratio is common in PCOS formulations, reflecting the natural ratio found in healthy ovarian tissue.
A quality supplement routine can make a real difference to your results.
Leave a Reply